Hs-CRP and HOMA-IR: Include them in the MASLD definition, or treat them as mediators between MASLD and atherosclerotic cardiovascular disease?

IF 26.8 1区医学 Q1 GASTROENTEROLOGY & HEPATOLOGY

Journal of Hepatology Pub Date : 2025-01-01 Epub Date: 2024-08-18 DOI:10.1016/j.jhep.2024.08.005

Heng Wan, Zihao Gui, Lan Liu, Ningjian Wang, Jie Shen

引用次数: 0

查看原文本刊更多论文

Hs-CRP和HOMA-IR：将其纳入MASLD定义，还是将其作为MASLD和动脉粥样硬化性心血管疾病之间的媒介？

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Hepatology 医学-胃肠肝病学

CiteScore

46.10

自引率

4.30%

发文量

2325

审稿时长

30 days

期刊介绍： The Journal of Hepatology is the official publication of the European Association for the Study of the Liver (EASL). It is dedicated to presenting clinical and basic research in the field of hepatology through original papers, reviews, case reports, and letters to the Editor. The Journal is published in English and may consider supplements that pass an editorial review.